Company Directory / Biotechnology Research
Public · NASDAQ:HRTXFor profitBiotechnology ResearchSan Diego, CA, United States
Heron Therapeutics
Heron Therapeutics is a biotechnology firm specializing in polymer-based pharmaceuticals.
- Founded
- 1983 43 years ago
- Staff
- 101-250 181 on LinkedIn
- Followers
- 15k on LinkedIn
- Funding
- $974M as listed, USD
Heron Therapeutics, Inc. (formerly A.P. Pharma, Inc.) is a specialty pharmaceutical company developing products using its proprietary Biochronomer™ polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks.
Set against six million companies
Size
101-250 people: larger than 85% of companies with a size listed. 181 people list it on LinkedIn.
Age
43 years old.
Reach
Website ranked #1,320,764 in the world for traffic, about 20k visits a month. 14,972 followers on LinkedIn.
What it does
BiotechnologyHealth CareTherapeuticsChemotherapy Induced Nasea and Vomiting (CINV)Post-Surgical Pain
Funding, as listed
$974M raised in total
- Rounds11
- LatestPost ipo equity, Jul 2023
- Latest amountUSD 30,000,000
- Investors9, 3 leading
What the source datasets report. We have not watched these rounds ourselves, and do not hold this company in the startups database.
Every detail we hold
Everything the source datasets list about Heron Therapeutics, field by field. Contact details are held but never shown.
The company
- Name
- Heron Therapeutics
- Type
- For profit
- Status
- Public · NASDAQ:HRTX
- Founded
- 1983
- Founders
- Barry Quart
- Industry
- Biotechnology Research
- Categories
- Biotechnology, Health Care, Therapeutics
- Specialities
- Chemotherapy Induced Nasea and Vomiting (CINV), Post-Surgical Pain
Where
- City
- San Diego
- Region
- CA
- Country
- United States
- Markets
- San Francisco Bay Area, Silicon Valley, West Coast, Western US
Size and reach
- Staff band
- 101-250
- People on LinkedIn
- 181
- LinkedIn followers
- 14,972
- Web traffic rank
- #1,320,764
- Monthly web visits
- 20,127
Funding, as listed
- Total
- $974,050,000 USD
- Rounds
- 11
- Latest round
- Post ipo equity
- Latest round date
- Jul 2023
- Latest amount
- 30,000,000 USD
- Investors
- 9
- Lead investors
- 3
- Stock listing
- NASDAQ:HRTX
- Listing status
- public
About this record
- Sources
- Crunchbase, LinkedIn
- Last imported
- Sept 2026
Growth, as the source summarises it
Heron Therapeutics reported surpassing revenue estimates for Q1 2024 and beating expectations for its full-year 2023 earnings.
Summaries written by the source dataset, not by us, and not checked.
Companies like it
Biotechnology Research in United States.
Global Blood TherapeuticsSouth San Francisco · 251-500 people · 23k followers
Editas MedicineCambridge · 251-500 people · 49k followers
Cogent BiosciencesWaltham · 101-250 people · 13k followers
CueSan Diego · 1001-5000 people · 23k followers
Recursion PharmaceuticalsSalt Lake City · 501-1000 people · 65k followers
Apeel SciencesGoleta · 101-250 people · 37k followersFrom the company datasets we hold (Crunchbase, LinkedIn and Apollo listings), as listed there; 1,637,054 companies in United States and 5,926,251 in all. We hold no contact details for public display. Correct this, or ask for it to be removed.